期刊:Current Opinion in Pulmonary Medicine [Ovid Technologies (Wolters Kluwer)] 日期:2018-01-01卷期号:24 (1): 94-103被引量:23
标识
DOI:10.1097/mcp.0000000000000437
摘要
Purpose of reviewMetabolomics has been used to uncover the metabolic signatures of asthma, both for biomarker identification and pathophysiologic mechanisms research. We aimed to review recent advances in this field, published since 2016, and discuss these findings implications to future research an